Erdafitinib exerts the anticancer effect on urothelial carcinoma via induction of authophagy.
Sign Up to like & getrecommendations! Published in 2020 at "Die Pharmazie"
DOI: 10.1691/ph.2020.9911
Abstract: Erdafitinib has recently been approved for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma (UC). The current study aimed to evaluate whether erdafitinib inhibits the proliferation in UC via inducing authophagy.… read more here.
Keywords: showed erdafitinib; authophagy; urothelial carcinoma; cell ... See more keywords